Fly Insider: Kinnate Biopharma, Arrowhead among week’s notable insider trades

Kinnate Biopharma director Tananbaum purchased $4.98M in shares, while Arrowhead Pharmaceuticals chairman Given sold $266K in shares

Welcome to "Fly Insider," The Fly’s weekly recap of notable insider stock transactions.

NOTABLE INSIDER PURCHASES: Significant insider purchases reported in the prior week from May 8 through May 12 include:

•  Chairman of Pulse Biosciences (PLSE) Robert Duggan purchased 10,022,937 shares of company stock at $6.51 per share for a total transaction amount of $65,249,320

• Director of Coinbase Global (COIN) Frederick Ehrsam purchased 810,000 shares of company stock at $61.77 per share for a total transaction amount of $50,034,996

• Director of Kinnate Biopharma (KNTE) James Tananbaum purchased 1,780,000 shares of company stock at $2.80 per share for a total transaction amount of $4,984,000

• Shareholder of Bread Financial Holdings (BFH) Turtle Creek purchased 257,618 shares of company stock at $24.88 per share for a total transaction amount of $6,409,536

NOTABLE INSIDER SALES: Significant insider sales reported in the prior week from May 8 through May 12 include:

• Officer of Arthur J Gallagher (AJG) Richard Cary sold 3,204 shares of company stock at $217.62 per share for a total transaction amount of $697,254

• Chairman of Arrowhead Pharmaceuticals (ARWR) Douglas Given sold 6,500 shares of company stock at $40.90 per share for a total transaction amount of $265,850

• CEO of Bright Horizons Family Solutions (BFAM) Howard Stephen sold 14,800 shares of company stock at $87.99 per share for a total transaction amount of $1,302,187 

• Beneficial Owner of Alphatec (ATEC) Paul Segal sold 167,496 shares of company stock at $14.88 per share for a total transaction amount of $2,492,340

NOTABLE PRICE MOVEMENT AFTER INSIDER TRANSACTION: Shares of Kinnate Biopharma are up over 55% since director James Tananbaum purchased 1.78M shares of company stock at $2.80 per share,  while shares of Arrowhead Pharmaceuticals fell by approximately 7% after chairman Douglas Given sold 6,500 shares of company stock at $40.90 per share.

Keywords: insider trading, insider buying, insider selling, executive trading, executive buying, executive selling, stock transactions, SEC